Opioid REMS Advisory Committee May Tackle Mandatory Education
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA notes its FDAAA mandate in scheduling the two-day review, but will meeting focus on reducing burden to health care system or increasing requirements?